Why Thai FDA Rejects Medical Device Registrations

Every year, a significant number of Thai FDA medical device registration rejections and major delays occur, not because of defective products, but because of poorly prepared regulatory submissions.

Medical device registration in Thailand is not a simple administrative filing. It is a structured regulatory project that requires correct classification, consistent technical documentation, and a clear local regulatory strategy.

Understanding the most common causes of rejection allows manufacturers to significantly increase approval probability and reduce time to market.

Wrong Product Classification

Product classification is the foundation of any Thai FDA submission.

A device classified incorrectly will automatically trigger regulatory objections, additional document requests, or rejection.

Common causes:

• Assuming Thailand classification is identical to ASEAN, EU or China

• Using outdated classification rules

• Underestimating risk class based on intended use

Even small differences in wording of intended use can move a product from Class I to Class II or III, completely changing documentation requirements.

Correct classification must always be verified against current Thai FDA rules, not copied from other markets.

Incomplete or Inconsistent Technical Documentation

Thai FDA carefully reviews internal consistency between documents.

Typical issues include:

• Device description not matching labeling

• Intended use in IFU different from submission form

• Technical specifications inconsistent across documents

• Missing accessories or components

These inconsistencies are interpreted as lack of control over the product.

A strong submission uses a single technical narrative that is coherent across all documents.

Poorly Prepared Clinical or Performance Evidence

Many manufacturers misunderstand when clinical or performance data are required.

Common mistakes:

• Submitting irrelevant clinical literature

• Using data from non-equivalent devices

• Providing summaries without clear justification

• Test reports not compliant with Thai Standards – see an example of standard equivalence

Thai FDA expects evidence to directly support the claimed intended use and safety profile.

When equivalence is claimed, the equivalence rationale must be clearly documented and defensible.

Manufacturer Site Not Aligned With QMS Expectations

ISO 13485 certification alone is not always sufficient.

Thai FDA also reviews:

• Scope of certification

• Manufacturing activities covered

• Consistency between site address and certificates

• Subcontracted processes

If the manufacturing site does not clearly match the device being registered, additional clarification will be requested.

Missing or Incorrect Local Regulatory Setup

Before registration can start, several local elements must be in place:

• Thai import license for medical devices

• Authorized representative

• Proper latter of authorization

Starting a submission without this structure leads to immediate delays.

Regulatory sequence matters.

Treating Registration as Paperwork Instead of a Regulatory Project

One of the most frequent root causes of failure is the assumption that Thai FDA registration is only a document translation exercise.

In reality, it is a strategic regulatory process involving:

• Product positioning

• Risk management logic

• Evidence selection

• Interaction with Thai FDA reviewers

Submissions prepared as simple paperwork exercises almost always encounter serious problems.

How to Increase Approval Probability

Manufacturers can significantly improve success rates by:

• Confirming classification before dossier preparation

• Building a unified technical narrative

• Verifying manufacturer certificates and scope

• Establishing local regulatory structure early

• Conducting a gap analysis before submission

A preliminary regulatory assessment often prevents months of delay.

Conclusion

Thai FDA rejection is rarely caused by a “bad product”.
It is usually caused by a weak regulatory strategy.

Manufacturers who approach Thai FDA registration as a structured regulatory project, rather than an administrative formality, achieve faster approvals and more predictable outcomes.